Health: RSV Immunisation

Lord Kamall Excerpts
Wednesday 17th January 2024

(11 months ago)

Lords Chamber
Read Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Lord Markham Portrait Lord Markham (Con)
- View Speech - Hansard - - - Excerpts

The JCVI process is similar to the NICE approach. They look through the quality-adjusted years framework and make sure that it reaches within that. That is how they came up with their calculations. So far it is only the older ones, 75-plus, that they think are enough of an at-risk group in terms of hospitalisations and mortality to justify that. But I will inquire further and get back to the noble Baroness I am sure that they are capturing the data so that we can check on the younger ages.

Lord Kamall Portrait Lord Kamall (Con)
- View Speech - Hansard - -

My Lords, a number of noble Lords referred to the fact that there were disparities between different communities in the take-up of previous vaccines. My noble friend the Minister acknowledged that. Given the experience of previous vaccine rollouts, what specific lessons has his department learned that it will put into practice to make sure that it reaches some of those hard-to-reach communities in the rollout of those vaccines?

Lord Markham Portrait Lord Markham (Con)
- View Speech - Hansard - - - Excerpts

You have to have the data and the records so that those who you know have not been vaccinated you have to go and get specifically. In London we have been running an under-fives programme, calling all those who have not been vaccinated to come and get a vaccine. That will be rolled out to under-11s and even up to under-25s, having learned precisely those lessons.